Sort
53,477 grants matching “addiction”
Alcohol Research Center - Treatment and Implications
$1,552,591Howard C. Becker · Medical University Of South Carolina · P50 · FY2022 · AA
Wireless Magnetomechanical Neuromodulation of Targeted Circuits
$1,552,535Polina O Anikeeva · Massachusetts Institute Of Technology · R01 · FY2020 · NS
Data Science Research
$1,551,398Paul M Thompson · University Of Southern California · U54 · FY2015 · EB
Opioid use disorders: UF Pharmacy medications discovery and development
$1,551,049Lance R McMahon · University Of Florida · UG3 · FY2020 · DA
Clinical Trials Network: The Texas Node
$1,550,000Madhukar H Trivedi · Ut Southwestern Medical Center · U10 · FY2010 · DA
Novel Therapeutics for Opioid Use Disorder in the Acute Overdose and Maintenance Settings
$1,549,446Donald R Gehlert · Epiodyne, Inc. · UH3 · FY2023 · DA
Alcohol Research Center - Treatment and Implications
$1,549,267Howard C. Becker · Medical University Of South Carolina · P50 · FY2021 · AA
Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes
$1,548,605Rosemarie A Martin · Univ Of Massachusetts Med Sch Worcester · RM1 · FY2025 · DA
Yale/NIDA Neuroproteomics Center
$1,548,122Kenneth Robert Williams · Yale University · P30 · FY2017 · DA
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
$1,547,949William R Sellers · Dana-Farber Cancer Inst · P50 · FY2021 · CA
DRUG ABUSE TREATMENT EVALUATION CENTER
$1,546,086University Of Pennsylvania · P50 · FY2004 · DA
8/24 The Healthy Brain and Child Development National Consortium
$1,545,992Moriah E Thomason · New York University School Of Medicine · U01 · FY2022 · DA
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
$1,545,717Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2018 · CA
Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy
$1,545,000Ohannes Kevork Melemedjian · University Of Maryland Baltimore · R01 · FY2020 · CA
Yale/NIDA Neuroproteomics Center
$1,544,774Kenneth Robert Williams · Yale University · P30 · FY2018 · DA
4/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium
$1,544,172Stephanie L Merhar · Cincinnati Childrens Hosp Med Ctr · U01 · FY2022 · DA
A Quantitative Proteomics Platform to Characterize the Nicotine-Dependent Brain
$1,543,823Benjamin F Cravatt · Scripps Research Institute, The · RC2 · FY2009 · DA
ANTISOCIAL DRUG DEPENDENCE--GENETICS AND TREATMENT
$1,542,426University Of Colorado Denver · P60 · FY2000 · DA
Non-opiate topical formulations for treating pain associated with molar extractions
$1,542,183Alan Parr · Arcato Laboratories, Inc. · R44 · FY2021 · DE
Structural basis for the functions of dopamine receptors and transporter
$1,541,058Lei Shi · National Institute On Drug Abuse · ZIA · FY2016 · DA
Wake Forest Translational Alcohol Research Center (WF-TARC)
$1,540,337Jeffrey L. Weiner · Wake Forest University Health Sciences · P50 · FY2025 · AA
Therapeutic Opportunities for Pediatric Astrocytoma
$1,540,004Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2014 · CA
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On
$1,539,787Tami L Mark · Research Triangle Institute · RM1 · FY2023 · DA
Brain Imaging of Human Drug Abuse
$1,539,763Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2020 · DA
NX90: A Treatment for Overdose Caused by High Potency Opioids
$1,539,426Michael V. Voronkov · Serodopa Therapeutics Inc · R44 · FY2024 · DA